Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miracus Patch Tetanus Vaccine FIH Study
NCT07624669Phase 4Not yet recruiting
- Sponsor
- Microneedle Solutions
- Start
- Aug 2026
- Primary completion
- Sep 2026
01
Overview
A Phase 4 trial of tetanus toxoid in Tetanus, sponsored by Microneedle Solutions. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tetanus toxoid
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT07624669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07624669.